Growth Metrics

Envoy Medical (COCH) Preferred Stock Liabilities (2021 - 2026)

Envoy Medical's Preferred Stock Liabilities history spans 5 years, with the latest figure at $391000.0 for Q1 2026.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A to $391000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $391000.0, a N/A change, with the full-year FY2025 number at $391000.0, changed N/A from a year prior.
  • Preferred Stock Liabilities hit $391000.0 in Q1 2026 for Envoy Medical, roughly flat from $391000.0 in the prior quarter.
  • Over the last five years, Preferred Stock Liabilities for COCH hit a ceiling of $429.7 million in Q4 2022 and a floor of $130000.0 in Q3 2025.
  • Historically, Preferred Stock Liabilities has averaged $199.6 million across 4 years, with a median of $44.6 million in 2023.
  • Biggest five-year swings in Preferred Stock Liabilities: increased 1.12% in 2022 and later plummeted 89.61% in 2023.
  • Tracing COCH's Preferred Stock Liabilities over 4 years: stood at $429.7 million in 2022, then crashed by 89.62% to $44.6 million in 2023, then tumbled by 99.12% to $391000.0 in 2025, then changed by 0.0% to $391000.0 in 2026.
  • Business Quant data shows Preferred Stock Liabilities for COCH at $391000.0 in Q1 2026, $391000.0 in Q4 2025, and $130000.0 in Q3 2025.